Localized Surface Plasmon Resonance of Metallic Nanoparticles--Optical Property Characterization for Rational Applications

在光的激发下金属纳米结构中的自由电子能够发生群体性的振荡，进而产生表面等离激元（SPP）。发生等离激元共振时，金属纳米结构会将光束缚在表面，并在表面产生极强的电场增强。表面等离激元有两种类型：一类具有传播的特点，其表面等离激元能够在表面传播，称之为propagatingSPP；另一类不具有传播性，共振局域在一个很小的金属结构中，称之为localizedSPP，即局域表面等离激元共振（LSPR）。金属纳米颗粒就具有很强的表面等离激元共振的（LSPR）性质，使其对光产生增强的吸收和增强的散射，并表现出相关的热、光电场增强和热电子等效应。近年，随着纳米科技的发展，金属纳米粒子的LSPR效应已经成为一...The collective oscillation of free electrons in metal nanostructures excited with light is called surface plasmon polaritons (SPP). The light will be confined to a small area on the surface under the resonance condition (SPR), thus a giant enhancement in the electric field will be produced. There are two kinds of surface plasmon polaritons (SPP): one is propagating plasmon polaritons (PSPP), which...学位：理学博士院系专业：化学化工学院_物理化学(含化学物理)学号：2052010015366

Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation

La lutte contre la maltraitance animale est sans conteste une cause moralement juste. Mais elle ne justifie en rien la désinformation à laquelle certaines associations qui s’en réclament ont recours pour remettre en question l’usage de l’expérimentation animale en recherche

Etude de validation d'une procédure de détection téléphonique de la gonarthrose symptomatique

BREST-BU Médecine-Odontologie (290192102) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Etude de validation d'une procédure de détection téléphonique de la gonarthrose symptomatique

BREST-BU Médecine-Odontologie (290192102) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Rituximab therapy for hairy cell leukemia : a retrospective study of 41 cases

The purine analogs (PAs) cladribine and pentostatin have transformed the prognosis of hairy cell leukemia (HCL). However, some patients still relapse after PAs, or fail to reach an optimal response, and new agents are needed to further improve treatment outcome. We retrospectively studied 41 HCL patients from 10 centers in France and Belgium, who received 49 treatment courses with the anti-CD20 monoclonal antibody rituximab. Most of the patients were treated at relapse (84 % of cases) and rituximab was combined to a PA in 41 % of cases. Overall, response rate is 90 % including 71 % complete hematologic responses (CHRs). Frontline treatment, combination therapy, and absolute neutrophil count were associated with response in multivariate analysis. Three-year relapse-free and overall survivals are 68 and 90 %, respectively. When combined to a PA, rituximab yields a 100 % response rate, even beyond frontline therapy. In contrast, response rate is only 82 % (59 % CHR) when rituximab is used alone. In this latter setting, relapse rate is 56 % and median time to relapse is 17.5 months. All eight patients who were treated two times with the antibody responded again to retreatment. We confirm the high efficacy of the combination rituximab + PA. However, when rituximab is used as monotherapy, response rate is lower and the high relapse rate is a concern. Prospective clinical trials are needed to confirm the superiority of the combination rituximab + PA over PA alone, both as frontline therapy and at relapse

Prevalence and determinants of coronary and aortic calcifications assessed by chest CT in renal transplant recipients.

BACKGROUND: Coronary artery calcifications independently predict cardiovascular events (CVE) in the general population. We assessed the prevalence and determinants of coronary (CAC) and thoracic aorta (AoC) calcifications in renal transplant recipients (RTR). METHODS: Consecutive RTR living in Belgium, with an isolated kidney graft functioning for more than 1 year, were asked to participate. They underwent a 16-slice spiral computerized tomography in order to measure calcium mass. Demographic, clinical, biochemical and urinary parameters were recorded. RESULTS: We included 281 patients. CAC and AoC were detected in 81 and 85%, with geometric means (SD) of 52.2 (4.9) and 99.3 (8.2) mg, respectively. By multiple linear regression, independent predictors of both types of calcifications included older age, longer time on dialysis, a history of CVE, of multiple transplantations and of smoking. Other determinants of CAC were male gender, current statin use and history of parathyroidectomy, and other determinants of AoC included higher pulse pressure, shorter time under mycophenolate mofetil and current use of anti-vitamin-K. CONCLUSION: The prevalence of both CAC and AoC is substantial in RTR. We delineate independent determinants either common to both CAC and AoC or specific to one, and known as classic or chronic kidney disease related risk factors